← Back to Archive

"Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors"

by Dumbrava et al.

February 26, 2026 · Version 1

Download PDF

Any comments you make here are private. They will be sent directly to our editors.